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Background Compared with coronary computed
tomographic angiography (CCTA), the coronary artery
calcium score (CACS) may be limited in predicting adverse
cardiovascular events in asymptomatic diabetic patients.
Methods We evaluated the predictive value of CACS for
obstructive coronary plaques (OCPs) assessed by CCTA
in 328 consecutive asymptomatic patients with type 2
diabetes mellitus who had an estimated glomerular
filtration rate greater than 60ml/min/1.73m2.
Results In total, 29 (9%) patients had OCPs: calcified or
mixed OCPs and noncalcified OCPs were found in 26 (8%)
and three (1%) patients, respectively. On the basis of a
CACS of 0, 1–10, 11–100, and greater than 100, OCPs were
found in 2, 5, 15, and 36% of patients, respectively. On
receiver operating characteristic curve analysis, the optimal
cutoff CACS for predicting OCPs was found to be 33, with
83% sensitivity and 81% specificity (area under the curve,
0.853; 95% confidence interval, 0.777–0.930; P< 0.001).
Positive and negative predictive values of a CACS of 33 for
OCPs were 30 and 98%, respectively. On multivariate
logistic regression analysis, age [odds ratio (OR), 1.09],
microalbuminuria (OR, 3.43), current smoking (OR, 3.93),
and CACS greater than 33 (OR, 15.85) were found to be
independently associated with an increased risk for OCPs
(P< 0.05, respectively). The predictive significance of CACS
greater than 33 for OCPs improved after considering the
status of microalbuminuria and current smoking.
Conclusion These findings suggest that CACS is an
effective gatekeeper for evaluating obstructive coronary
artery disease using CCTA in asymptomatic Korean patients
with type 2 diabetes mellitus who have near-normal kidney
function. Coron Artery Dis 26:150–156 Copyright © 2015
Wolters Kluwer Health, Inc. All rights reserved.
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Introduction
Diabetes is strongly associated with adverse cardiovas-
cular (CV) events [1]. Coronary artery disease (CAD) is
the major cause of mortality among diabetic patients,
accounting for 75% of deaths in this population [2].
However, myocardial ischemia in patients with diabetes
is often asymptomatic and frequently manifests clinically
in the advanced stage [3,4]. Given these associations
between CAD and diabetes, screening for obstructive
CAD in asymptomatic diabetic patients is of importance.
The coronary artery calcium score (CACS), which was
developed to quantify the extent of coronary calcification
[5], is a good marker of the degree of atheromatous
plaque burden [6,7]. CACS is an independent predictor
of coronary events and improves CV risk prediction in
asymptomatic individuals [7–9]. However, CACS may
have limited predictive value for adverse coronary events
in diabetic patients compared with nondiabetic indivi-
duals, although the risk for coronary events increases with
increasing calcium scores and diabetes status among
asymptomatic individuals [10]. This implies that CACS
more accurately reflects the total atheromatous plaque
burden rather than the presence of obstructive coronary
plaques (OCPs) despite the incremental impact of dia-
betes on coronary atherosclerosis.
Coronary computed tomographic angiography (CCTA) is
a novel, noninvasive imaging approach for evaluating
coronary atherosclerosis, with a high diagnostic accuracy
for detecting coronary plaques [11–13]. A recent study
has reported that the severity of CAD assessed by CCTA
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is
permissible to download and share the work provided it is properly cited. The work
cannot be changed in any way or used commercially.
150 Original research
0954-6928 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. DOI: 10.1097/MCA.0000000000000184
is independently associated with adverse clinical out-
comes in diabetic patients [14]. Thus, the identification
of obstructive CAD may be important in asymptomatic
diabetic patients for CV risk stratification. However, the
routine use of CCTA for CV risk assessment of asymp-
tomatic individuals has not been recommended, irre-
spective of the presence of diabetes [15]. Although the
application of CCTA on the basis of CACS may be a
useful method for evaluating obstructive CAD in
asymptomatic diabetic patients, data on the association
between CACS and obstructive CAD are limited, espe-
cially in the Asian population. In the present study, we
investigated the predictive value of CACS for obstructive
CAD assessed by CCTA in 328 consecutive asympto-
matic Korean patients with type 2 diabetes mellitus
(T2DM) who had an estimated glomerular filtration rate
(GFR) greater than 60 ml/min/1.73 m2.
Materials and methods
Participants
This cross-sectional study included 328 consecutive
asymptomatic patients with T2DM who underwent
CCTA between January 2008 and December 2009 at
Severance Cardiovascular Hospital. None of the patients
had CV symptoms, including typical angina, atypical
angina, dyspnea, and excessive fatigue. Exclusion criteria
were age less than 35 years, type 1 diabetes mellitus,
ECG evidence of Q-wave myocardial infarction, ischemic
ST-segment or T-wave changes, or complete left-bundle
branch block, a clinical history of CV disease, cere-
brovascular disease, or malignancy, and an estimated
modification of diet in renal disease GFR less than 60 ml/
min/1.73 m2. All participants provided informed consent,
and the study protocol was approved by the ethics com-
mittee of our institution.
Multidetector computed tomography protocol
Participants with an initial heart rate of at least 65 beats/min
before undergoing multidetector computed tomography
(CT) received a single oral dose of 50mg metoprolol tar-
trate (Betaloc; Yuhan, Seoul, South Korea) 1 h before CT
examination, unless treatment with a β-blocker was con-
traindicated because of heart failure, atrioventricular con-
duction abnormalities, or bronchial asthma. Imaging was
performed for all patients using a 64-slice CT scanner
(Sensation 64; Siemens Medical System, Forchheim,
Germany). All CT examinations were performed during
breath holding in inspiration. Initially, a nonenhanced
prospective ECG-gated scan to evaluate CACS was per-
formed with the following parameters: rotation time of
330ms, slice collimation of 0.6mm, slice width of 3.0mm,
tube voltage of 100–120 kV, tube current of 50mA, and
table feed/scan of 18mm. Thereafter, CCTA was per-
formed using retrospective ECG gating with the following
scan parameters: rotation time of 330ms, slice collimation
of 64× 0.6mm, tube voltage of 100–120 kV, tube current of
400–800mA (depending on the patient size), table feed/
scan of 3.8mm, and pitch factor of 0.2. ECG-based tube
current modulation was applied to 65% of the R–R interval.
A real-time bolus-tracking technique was applied to trigger
the initiation of the scan. Contrast enhancement was
achieved with 60ml iopamidol (370mg/ml iodine,
Iopamiro; Bracco, Milan, Italy) injected at 5ml/s, followed
by injection of 30ml diluted contrast medium (saline–-
contrast agent ratio of 7 : 3) and then 30ml saline at 5ml/s
with a power injector (Envision CT; Medrad, Indianola,
Pennsylvania, USA) through an antecubital vein. Image
reconstruction was performed in the scanner workstation
using commercially available software (Wizard; Siemens
Medical Solutions). Axial images were reconstructed ret-
rospectively at 65% of the R–R interval for each cardiac
cycle. If artifacts were present, additional data sets were
obtained for various points of the cardiac cycle, and the
data set with the minimum artifact was selected for further
analysis. The reconstructed image data sets were trans-
ferred to an offline workstation (Aquar-ius Workstation;
TeraRecon Inc., San Mateo, California, USA). Each lesion
identified was examined using maximum intensity pro-
jection and multiplanar reconstruction techniques on a
short axis and along multiple longitudinal axes. Lesions
were classified by the maximal stenosis of luminal diameter
observed on any plane.
Coronary calcium and plaque measurement
All CCTA results were evaluated by two experienced
cardiac radiologists (Y.J.K. and B.-W.C., who had 6 and
9 years of experience, respectively, in cardiac CT). In the
case of disagreement, a joint reading was performed to
reach a consensus. This study evaluated the association
between CACS and the presence of any plaque and
OCPs. CACS was evaluated on the basis of the scoring
system, using a previously described method [5]. Because
the frequency of CACS greater than 100 in the Asian
population is known to be low compared with that among
African-American, Caucasian, and Hispanic populations
[16] and because a few participants in the present study
had CACS greater than 400 (7%), the participants were
categorized by a CACS of 0, 1–10, 11–100, and greater
than 100. Plaques or OCPs were classified into two
subtypes according to the presence of coronary calcifi-
cation – that is, calcified or mixed plaque and non-
calcified plaque. Plaques were defined as structures
greater than 1 mm2 within and/or adjacent to the vessel
lumen that were clearly distinguished from the lumen
and surrounding pericardial tissue, and OCPs were
defined as plaques with stenosis of at least 50% luminal
diameter. Obstructive CAD was defined by the presence
of OCPs on CCTA.
Biochemical and clinical parameters
Information on current smoking and a history of hyper-
tension, dyslipidemia, and diabetes was systematically
collected. Height, weight, and blood pressure were
measured during hospital visits. All blood samples were
CACS and obstructive plaque in T2DM Won et al. 151
obtained after a minimum of 8 h of fasting and analyzed
for lipid profiles, including triglyceride, high-density
lipoprotein cholesterol, low-density lipoprotein choles-
terol, and glucose levels. BMI was calculated as weight
(kg) divided by height (m2), and obesity was defined as a
BMI of at least 25 kg/m2. Kidney function was assessed
on the basis of the estimated GFR calculated using the
formula validated in the modification of diet in renal
disease study [17]. The albumin-to-creatinine ratio in
untimed spot urine was used for assessing proteinuria as
recommended [18]. Spot urine albumin-to-creatinine
ratio greater than 17 mg/g (men) or greater than 25mg/g
(women) was defined as microalbuminuria. The partici-
pant was considered a current smoker if he/she con-
sistently smoked or smoked within 1 month before the
study. Hypertension was defined as a systolic blood
pressure of at least 140 mmHg and/or a diastolic blood
pressure of at least 90 mmHg, or by treatment with
antihypertensive agents. Dyslipidemia was defined as a
total cholesterol level of at least 240mg/dl, a low-density
lipoprotein level of at least 130 mg/dl, a high-density
lipoprotein level of up to 40 mg/dl, a triglyceride level of
at least 150 mg/dl, and/or treatment with lipid-lowering
agents. Diabetes was defined as either a fasting glucose
level of at least 126mg/dl, a referral diagnosis of diabetes,
or the presence of antidiabetic treatment.
Statistical analysis
Values are expressed as mean ± SD for continuous vari-
ables and numbers and percentages for categorical vari-
ables. Continuous variables were compared using
Student’s t-test, and categorical variables were compared
using the χ2-test or Fisher’s exact test, as appropriate.
Receiver operating characteristic curve analysis using the
Youden index was carried out to determine the optimal
cutoff CACS for predicting OCPs. Univariate logistic
regression analysis was carried out to identify the impact
of an individual CV risk factor on OCPs, and multivariate
logistic regression analysis was carried out to identify
independent determinants of OCPs. We then compared
the predictive significance of the optimal cutoff CACS
for OCPs after considering independent risk factors.
All analyses were carried out using SAS (version 9.1.3;
SAS Institute Inc., Cary, North Carolina, USA). A P-value
less than 0.05 was considered statistically significant.
Results
The baseline characteristics of the 328 patients
(53± 9 years, 77% men) in this study are shown in
Table 1. Hypertension, dyslipidemia, and obesity were
present in 39, 60, and 46% of the participants, respec-
tively. The incidence of microalbuminuria and current
smoking was 26 and 34%, respectively. The mean CACS
was 80± 241, and the incidence of the CACS categories 0,
1–10, 11–100, and greater than 100 was 62, 7, 17, and 14%,
respectively. Forty-six percent of the patients had pla-
ques, with calcified or mixed plaques and noncalcified
plaques found in 38 and 8%, respectively. Nine percent of
the patients had OCPs, with calcified or mixed OCPs and
noncalcified OCPs found in 8 and 1%, respectively. OCPs
were found in 2, 5, 15, and 36% of the patients belonging
to CACS categories 0, 1–10, 11–100, and greater than 100,
respectively (Fig. 1). On receiver operating characteristic
analysis, the optimal cutoff CACS for predicting OCPs, as
determined using the Youden index, was found to be 33,
with 83% sensitivity and 81% specificity [area under curve
Table 1 Baseline characteristics
Characteristics n=328
Patients
Age (years) 53 ±9
Men [n (%)] 252 (77)
BMI (kg/m2) 25.1 ±3.2
Obesity [n (%)] 151 (46)
Hypertension [n (%)] 129 (39)
Dyslipidemia [n (%)] 196 (60)
Current smoking [n (%)] 110 (34)
Total cholesterol (mg/dl) 199 ±38
Triglyceride (mg/dl) 159 ±99
HDL (mg/dl) 51 ±12
LDL (mg/dl) 107 ± 30
Creatinine (mg/dl) 1.1 ±0.1
Microalbuminuria [n (%)] 78 (24)
GFR (ml/min/1.73 m2) 75 ±11
Coronary artery
CACS 80 ±241
CACS=0 [n (%)] 204 (62)
0<CACS≤10 [n (%)] 22 (7)
10<CACS≤100 [n (%)] 55 (17)
CACS>100 [n (%)] 47 (14)
Any plaque [n (%)] 152 (46)
Calcified or mixed plaque [n (%)] 124 (38)
Noncalcified plaque [n (%)] 28 (8)
OCP [n (%)] 29 (9)
Calcified or mixed OCP [n (%)] 26 (8)
Noncalcified OCP [n (%)] 3 (1)
Data are expressed as n (%) or mean ±SD.
CACS, coronary artery calcium score; GFR, glomerular filtration rate; HDL, high-
density lipoprotein; LDL, low-density lipoprotein; OCP, obstructive coronary plaque.
Fig. 1
40%
30%
20%
10%
0%
CA
CS
 0
0<
CA
CS
≤1
0
10
<C
AC
S≤
 10
0
CA
CS
>1
00
OCP
The occurrence of OCPs according to the categorized CACS. CACS,
coronary artery calcium score; OCP, obstructive coronary plaque.
152 Coronary Artery Disease 2015, Vol 26 No 2
(AUC), 0.853; 95% confidence interval (CI), 0.777–0.930;
P< 0.001]. The positive and negative predictive values of
CACS 33 for OCPs were 30 and 98%, respectively
(Fig. 2).
The clinical characteristics of the participants according
to the presence of OCPs are shown in Table 2. The mean
age was significantly higher among T2DM patients with
OCPs than among those without OCPs. The incidence of
male sex, microalbuminuria, and CACS greater than 33
was significantly higher among T2DM patients with
OCPs than among those without OCPs.
Univariate logistic regression analysis showed that age
[odds ratio (OR), 1.08; 95% CI, 1.03–1.12; P= 0.010],
microalbuminuria (OR, 4.56; 95% CI, 2.05–10.15;
P< 0.001), and CACS greater than 33 (OR, 19.95; 95%
CI, 7.30–54.50; P< 0.001) were significantly associated
with an increased risk for OCPs. On multivariate logistic
regression analysis, age (OR, 1.09; 95% CI, 1.02–1.17;
P= 0.016), microalbuminuria (OR, 3.43; 95% CI,
1.31–8.99; P= 0.012), current smoking (OR, 3.93; 95%
CI, 1.26–12.28; P= 0.019), and CACS greater than 33
(OR, 15.85; 95% CI, 4.83–52.03; P< 0.001) were found to
be independently associated with an increased risk for
OCPs (Table 3).
The predictive significance of CACS greater than 33 for
OCPs improved after considering the status of micro-
albuminuria (CACS> 33AUC vs. CACS> 33 with micro-
albuminuria AUC: 0.816 vs. 0.862; P= 0.033) and both
microalbuminuria and current smoking (CACS> 33AUC
vs. CACS> 33 with microalbuminuria and current
smokingAUC: 0.816 vs. 0.864; P= 0.044; Table 4).
Discussion
Compared with CCTA, CACS may have a limited pre-
dictive value for adverse coronary events in asympto-
matic diabetic patients because CACS more accurately
reflects the total plaque burden rather than the presence
of OCPs despite the incremental impact of diabetes on
coronary atherosclerosis. Although the application of
CCTA based on the CACS may be a useful method for
evaluating obstructive CAD in asymptomatic diabetic
patients, data on the association between CACS and
obstructive CAD are scarce, especially in the Asian
population.
The association between diabetes and CV disease is well
established. CAD is the leading cause of death among
diabetic patients but is more often silent in patients with
diabetes [3,4]. Thus, screening for obstructive CAD in
asymptomatic diabetic patients is an appealing concept.
CACS, a coronary atherosclerotic surrogate marker, has
been extensively studied and is known to be an inde-
pendent predictor of coronary events that improves CV
risk prediction in asymptomatic individuals [7–9].
However, the South Bay Heart Watch study, which was
conducted on high-risk asymptomatic patients, showed
that CACS was not significantly associated with the
subsequent occurrence of CV events; however, CACS
was significantly higher in diabetic than in nondiabetic
individuals, with diabetic patients experiencing twice as
many CV events [10]. In contrast, the COronary CT
Angiography EvaluatioN For Clinical Outcomes: an
InteRnational Multicenter Registry (CONFIRM) study
recently reported that the severity of CAD assessed by
CCTA is independently associated with adverse clinical
outcomes in both nondiabetic and diabetic individuals
[14]. Accordingly, compared with CACS, the identifica-
tion of OCPs might be helpful in assessing CV risk
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Table 2 Comparison of clinical characteristics according to the
presence of OCPs
Obstructive CAD
negative (n=299)
Obstructive CAD
positive (n=29) P
Age (years) 53 ± 9 59 ± 9 0.001
Men [n (%)] 225 (75) 27 (93) 0.030
BMI (kg/m2) 25.1 ± 3.1 25.0 ± 3.5 0.797
Obesity [n (%)] 135 (45) 16 (55) 0.301
Hypertension [n (%)] 116 (39) 13 (45) 0.526
Dyslipidemia [n (%)] 176 (59) 20 (69) 0.289
Current smoking
[n (%)]
97 (32) 13 (45) 0.177
Total cholesterol
(mg/dl)
199 ± 37 202 ± 46 0.669
Triglyceride (mg/dl) 158 ± 97 172 ± 120 0.464
HDL (mg/dl) 51 ± 12 51 ± 14 0.829
LDL (mg/dl) 107 ± 29 108 ± 35 0.976
Creatinine (mg/dl) 1.1 ± 0.1 1.1 ± 0.2 0.859
Microalbuminuria
[n (%)]
62 (23) 16 (57) <0.001
GFR (ml/min/1.73 m2) 75 ± 9 79 ± 23 0.055
CACS>33 58 (19) 24 (83) <0.001
Data are expressed as n (%) or mean ±SD.
CACS, coronary artery calcium score; CAD, coronary artery disease; GFR, glo-
merular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
OCP, obstructive coronary plaque.
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stratification in asymptomatic diabetic patients. However,
the routine application of CCTA for CV risk assessment
in asymptomatic individuals has not been recommended
in clinical practice.
This study evaluated the association between CACS and
obstructive CAD in asymptomatic patients with T2DM
who had near-normal kidney function. A previous study
reported that silent myocardial ischemia, as assessed by
adenosine technetium-99m sestamibi single-photon emis-
sion computed tomography myocardial perfusion imaging,
occurred in more than one of five asymptomatic diabetic
patients in a western population [19]. Obstructive CAD
was found in 9% of the patients in the present study, which
is relatively low compared with the incidence in the
western population. This discrepancy might be associated
with ethnic differences in the development and progres-
sion of CAD and the evaluation method for obstructive
CAD. Although 9% of the patients in this study had OCP,
the occurrence of OCPs radically increased up to 36% in
patients with a CACS greater than 100. It is noteworthy
that in the patients of the present study almost all cases of
OCPs were accompanied by calcification. In the present
study, the optimal cutoff value of CACS for predicting
obstructive CAD was 33. This cutoff value had a very high
negative predictive value for obstructive CAD, ∼ 98%, and
a relatively high sensitivity and specificity for obstructive
CAD in asymptomatic patients with T2DM. In particular,
the predictive significance of a CACS of 33 for obstructive
CAD improved after considering the status of micro-
albuminuria and current smoking in asymptomatic patients
with T2DM.
The identification of obstructive CAD might be impor-
tant in asymptomatic diabetic patients. Stress testing and
the provocation of inducible ischemia have been mainly
used for identifying obstructive CAD but have limitations
because of a diminished diagnostic accuracy compared
with the gold standard of invasive coronary angiography.
On the basis of data from the National Cardiovascular
Data Registry, the rate of nonobstructive CAD identified
by invasive coronary angiography was 59% in patients
with a positive functional test results, and the rate of
negative stress test results was as high as 28% in patients
with obstructive CAD [20]. CCTA has been used as an
alternative to conventional invasive coronary angiography
for evaluating CAD because of its high diagnostic accu-
racy for detecting coronary plaque [11–13]. However,
CCTA is not recommended for the evaluation of CAD in
patients with severe coronary calcification and morbid
obesity because these factors may influence the image
quality. Clinical features of patients with T2DM in Asia
are different from those in other parts of the world, with
T2DM developing in patients with much lower BMI in
Asia compared with western countries [21]. In addition,
most Korean individuals with T2DM are not obese, even
with obesity defined as a BMI of more than 25 kg/m2 [22].
Further, Nasir et al. [16] reported that the frequency of a
CACS greater than 100 in the Asian population is sig-
nificantly low compared with that in western populations.
The mean CACS was 80± 241, and 14% of patients had
CACS greater than 100 in the present study of asympto-
matic patients with T2DM. Moreover, the mean BMI was
25.1±3.2 kg/m2 and 46% of the patients were obese,
defined by a BMI of more than 25 kg/m2. Therefore, the
use of CCTA based on CACS may be appropriate for
evaluating obstructive CAD in asymptomatic Korean
patients with T2DM who do not have significant dete-
rioration of kidney function.
Previous studies have reported that chronic kidney dis-
ease and traditional risk factors are associated with cor-
onary calcification [23] and that urinary albumin
excretion is significantly associated with coronary calci-
fication in asymptomatic diabetic patients [24]. However,
data on the association between microalbuminuria and
Table 3 Univariate and multivariate logistic regression analysis for identifying the determinants of OCPs
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Age 1.08 (1.03–1.12) 0.010 1.09 (1.02–1.17) 0.016
Male sex 4.44 (1.03–19.12) 0.045 2.64 (0.47–14.86) 0.272
Obesity 1.50 (0.70–3.22) 0.304 1.87 (0.66–5.31) 0.242
Hypertension 1.28 (0.60–2.76) 0.526 0.60 (0.22–1.67) 0.332
Dyslipidemia 1.55 (0.68–3.53) 0.293 1.77 (0.64–4.94) 0.274
Current smoking 1.69 (0.78–3.66) 0.181 3.93 (1.26–12.28) 0.019
Microalbuminuria 4.56 (2.05–10.15) <0.001 3.43 (1.31–8.99) 0.012
CACS>33 19.95 (7.30–54.50) <0.001 15.85 (4.83–52.03) <0.001
GFR 1.02 (0.99–1.05) 0.080 1.04 (0.99–1.09) 0.162
CACS, coronary artery calcium score; CI, confidence interval; GFR, glomerular filtration rate; OCP, obstructive coronary plaque; OR, odds ratio.
Table 4 Comparison of ROC models related to the cutoff value of
CACS>33 for predicting obstructive CAD
ROC models AUC (95% CI)
CACS>33 0.816 (0.740–0.892)
CACS>33 with microalbuminuria 0.862 (0.795–0.929)*
CACS>33 with microalbuminuria and current smoking 0.864 (0.782–0.945)†
AUC, area under the curve; CACS, coronary artery calcium score; CAD, coronary
artery disease; CI, confidence interval; ROC, receiver operating characteristic.
*P=0.033 vs. CACS>33.
†P=0.044 vs. CACS>33.
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obstructive CAD in asymptomatic diabetic patients with
preserved renal function are scarce. The present study
indicated that microalbuminuria is independently asso-
ciated with obstructive CAD and that the predictive value
of CACS for obstructive CAD significantly improved after
considering the status of microalbuminuria in asympto-
matic diabetic patients with near-normal kidney function.
The identification of microalbuminuria status might be
important when CACS is used as a screening tool for
evaluating obstructive CAD in this patient population.
The present study has some limitations. First, the asso-
ciation between CACS and obstructive CAD might be
different in asymptomatic diabetic patients according to
ethnicity, considering the differences clinical features of
T2DM between Asian and western populations. However,
the present study included only a Korean population.
Second, coronary calcification might be more pronounced
in elderly and male patients. However, we did not evaluate
the optimal cutoff CACS for obstructive CAD according to
different age groups and sex because of the relatively small
sample sizes in the present study. Finally, the present
study was retrospective and may have been influenced by
unobserved confounders and selection bias. Further pro-
spective studies with larger sample sizes are required to
address these issues.
Despite the limitations of the present study, it is unique in
that we identified the association between CACS and OCPs
in asymptomatic patients with T2DM who had preserved
renal function in an Asian population. Considering that the
clinical features of diabetic patients in an Asian population
might be explicitly different from those in a western
population [21], identification of the association between
CACS and obstructive CAD in asymptomatic Asian diabetic
patients might be important. The present study identified
that CACS is a useful screening tool for evaluating
obstructive CAD because noncalcified OCPs are extremely
rare in asymptomatic Korean patients with T2DMwho have
near-normal kidney function.
Conclusion
Compared with calcified or mixed OCPs, noncalcified
OCPs were scarcely observed in asymptomatic patients
with T2DM. Considering the high negative predictive
value of CACS for obstructive CAD, CACS may be used
effectively as a gatekeeper for evaluating obstructive
CAD using CCTA in asymptomatic Korean patients with
T2DM who have near-normal kidney function. In addi-
tion, consideration of the status of microalbuminuria and
current smoking may be important for the evaluation of
obstructive CAD on the basis of CACS in asymptomatic
patients with T2DM.
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